Skip to main content

Animations

MJFF Publications

3631 - 3640 of 6467 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2024
  • 2023
  • 2023
  • 2016
  • 2019
  • Summary Details
    OPEN
    Title: Targeting Rab‐RILPL interactions as a strategy to downregulate pathogenic LRRK2 in Parkinson's disease
    Journal Name: Journal of Peptide Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/psc.3563
    Citation Count: 4
  • The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?
    2023
    Summary Details
    OPEN
    Title: The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29688
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Toward Omics-Scale Quantitative Mass Spectrometry Imaging of Lipids in Brain Tissue Using a Multiclass Internal Standard Mixture
    Journal Name: Analytical Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.analchem.3c02724
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-023-12073-7
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Long-term exposure to low-level particulate air pollution and Parkinson's disease diagnosis - A Finnish register-based study
    Journal Name: Environmental Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.envres.2023.115944
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Genetic Modifiers of LRRK2 Parkinson's Disease: A Replication Study in Arab‐Berbers
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29735
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2023.106343
    Citation Count: 13
  • Summary Details
    OPEN
    Title: A role for the subthalamic nucleus in aversive learning
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2023.113328
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Design of a Multi-Pinhole Collimator for I-123 DaTscan Imaging on Dual-Headed SPECT Systems in Combination with a Fan-Beam Collimator
    Journal Name: IEEE Transactions on Nuclear Science
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/tns.2016.2515519
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/cts.12619
    Citation Count: 18
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.